• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

How the CellMist SkinGun heals: a Q&A with RenovaCare’s CEO

April 5, 2017 By Chris Newmarker

Heather Thompson, Senior Editor

RenovaCare CellMist SkinGunWhen Thomas Bold joined RenovaCare in 2013, he was already familiar with its potentially groundbreaking technology. Bold had served as StemCell Systems CEO in Berlin for many years. He was involved in the development of the CellMist and SkinGun – the platform technologies for RenovaCare Inc.

The technologies represent a shift in thinking about wound care, Bold said. Bold’s goal is to steer publically-traded RenovaCare to “market the world’s most advanced technology for skin repair using a patient’s own stem cells.” The company recently released the results of a case study featuring a burn victim who showed exceptional results. He answered some Medical Design & Outsourcing questions about the nature of RenovaCare’s technology and how he sees it developing in the future.

MDO: Can you describe RenovaCare’s platform technology?

Bold: For patients and surgeons, our development of spray-on stem cells for rapid and scar-free healing of severe second-degree burns is life-changing.

The CellMist system has two components: the CellMist solution, a water-based solution with the patient’s own stem cells, and the SkinGun, an ultra-gentle spray device which deposits the CellMist solution

A small sample of the patient’s healthy skin is processed to liberate the stem cells from surrounding tissue. The cells are suspended in a water-based solution, placed into a syringe, the syringe is attached to the SkinGun. For the spraying process, we use air flow to gently float the cells onto the wound.

With this technology, we are achieving incredible cell survival rates because the cells are never exposed to thrashing or turbulent forces. Cell survival and, consequently, the number of vital cells determine the ability to heal the wound. In-vitro studies have shown that our SkinGun achieves 97% cell survival.

A wound heals from the edges to the middle and the longer that takes the higher is the risk for inflammation and finally scarring.

With our technology, the stem cells act as thousands of little regenerative islands all over the wound where they will connect to each other and finally close the wound with an epithelial layer. Once this layer is closed, the wound is dry and considered to be healed. After this process, the cosmetic healing will happen all naturally and the result should be a skin that looks, feels and functions as it did before.

Get the full story on our sister site, Medical Design & Outsourcing.

Filed Under: Drug-Device Combinations, Featured, Stem Cells, Wound Care Tagged With: medtech, RenovaCare, stem cells, wound care

IN CASE YOU MISSED IT

  • Flat Medical partners with Mercury Medical on smart syringe distribution
  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS